Avantor (AVTR) Cash & Equivalents (2018 - 2026)
Avantor's (AVTR) quarterly Cash & Equivalents came in at $279.3 million in Q1 2026, down 11.53% year-on-year from $315.7 million in Q1 2025, and down 23.56% quarter-over-quarter from $365.4 million in Q4 2025.
Avantor (AVTR) Cash & Equivalents (2018 - 2026) Analysis & Trends
Avantor's Cash & Equivalents history runs 9 years deep, the most recent figure standing at $279.3 million for Q1 2026.
- On a quarterly basis, Cash & Equivalents fell 11.53% year-over-year to $279.3 million in Q1 2026; TTM through Mar 2026 was $279.3 million, a 11.53% decrease from a year earlier, with the FY2025 full-year figure at $365.4 million, up 39.52% from the prior year.
- Cash & Equivalents fell to $279.3 million in Q1 2026 per AVTR's latest filing, from $365.4 million in the prior quarter.
- Across five years, Cash & Equivalents topped out at $449.4 million in Q2 2025 and bottomed at $234.9 million in Q1 2024.
- The 5-year median for Cash & Equivalents is $272.6 million (2024), against an average of $288.6 million.
- Across the five-year window, Cash & Equivalents tumbled 81.38% in 2022 and jumped 64.86% in 2025, its largest moves.
- Year by year, Cash & Equivalents stood at $372.9 million in 2022, then retreated by 29.5% to $262.9 million in 2023, then dropped by 0.38% to $261.9 million in 2024, then surged by 39.52% to $365.4 million in 2025, then declined by 23.56% to $279.3 million in 2026.
- Per Business Quant, the three latest AVTR Cash & Equivalents figures stand at $279.3 million (Q1 2026), $365.4 million (Q4 2025), and $251.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 1.58 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 2.76 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 813.00 Mn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 2.24 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 1.66 Bn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 435.80 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 138.80 Mn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 561.00 Mn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 1.06 Bn |
| 10 | Avantor | 7.67 Bn | 7.39 Bn | 500.70 Mn | 279.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 279.30 Mn |
| Dec 31, 2025 | 365.40 Mn |
| Sep 30, 2025 | 251.90 Mn |
| Jun 30, 2025 | 449.40 Mn |
| Mar 31, 2025 | 315.70 Mn |
| Dec 31, 2024 | 261.90 Mn |
| Sep 30, 2024 | 285.30 Mn |
| Jun 30, 2024 | 272.60 Mn |
| Mar 31, 2024 | 234.90 Mn |
| Dec 31, 2023 | 262.90 Mn |
| Sep 30, 2023 | 236.90 Mn |
| Jun 30, 2023 | 236.40 Mn |
| Mar 31, 2023 | 294.60 Mn |
| Dec 31, 2022 | 372.90 Mn |
| Sep 30, 2022 | 265.60 Mn |
| Jun 30, 2022 | 237.50 Mn |
| Mar 31, 2022 | 283.60 Mn |
| Dec 31, 2021 | 301.70 Mn |
| Sep 30, 2021 | 1.43 Bn |
| Jun 30, 2021 | 223.00 Mn |